[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f0a2-YwL2q-ONKRS7ad72DKXwJC1a5PaDqIwa92-uJog":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":52,"rows":59},"Chinese Academy of Sciences",[4],64,false,11,6,34309972,3,31,[14,16,19,21,23,25,27,29],{"name":15,"count":9},"Obesity",{"name":17,"count":18},"Spinal Cord Injury",4,{"name":20,"count":18},"Healthy",{"name":22,"count":11},"Weight Loss",{"name":24,"count":11},"Metabolic Syndrome X",{"name":26,"count":11},"Breast Cancer",{"name":28,"count":11},"Vitamin D Deficiency",{"name":30,"count":31},"Hepatocellular Carcinoma",2,[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06035250","AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy","2024-08-31","Neoadjuvant Chemotherapy",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05047510","GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma","2025-12-31","Anti-GPC3-IRDye800CW",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06989177","Probiotic Intervention on Body Weight","2026-12-30","semaglutide",{"nctId":49,"briefTitle":50,"date":51,"intervention":47},"NCT06989203","Protein Supplementation Intervention on Body Weight","2026-12-31",[53,54,55,56,57,58],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[60,89,110,134,161,187,223,261,294,331,355,377,395,419,437,455,479,504,522,540,558,585,610,628,650,673,691,713,738,756,780,798,846,868,893,919,945,963,981],{"intervention":47,"totalTrials":31,"cells":61},{"EARLY_PHASE1":62,"PHASE1":65,"PHASE2":67,"PHASE3":69,"PHASE4":71,"NA":73},{"trials":63,"activeCount":64},[],0,{"trials":66,"activeCount":64},[],{"trials":68,"activeCount":64},[],{"trials":70,"activeCount":64},[],{"trials":72,"activeCount":64},[],{"trials":74,"activeCount":31,"soonestReadout":46},[75,83],{"nctId":49,"briefTitle":50,"status":76,"phases":77,"primaryCompletion":51,"completion":51,"start":78,"enrollment":79,"conditions":80,"interventions":82},"RECRUITING",[58],"2025-06-10",140,[15,22,81],"Protein Supplementation",[47],{"nctId":44,"briefTitle":45,"status":76,"phases":84,"primaryCompletion":46,"completion":51,"start":78,"enrollment":79,"conditions":85,"interventions":88},[58],[15,86,22,87],"Homeostasis","Probiotic Intervention",[47],{"intervention":42,"totalTrials":90,"cells":91},1,{"EARLY_PHASE1":92,"PHASE1":94,"PHASE2":96,"PHASE3":98,"PHASE4":100,"NA":102},{"trials":93,"activeCount":64},[],{"trials":95,"activeCount":64},[],{"trials":97,"activeCount":64},[],{"trials":99,"activeCount":64},[],{"trials":101,"activeCount":64},[],{"trials":103,"activeCount":90,"soonestReadout":41},[104],{"nctId":39,"briefTitle":40,"status":76,"phases":105,"primaryCompletion":41,"completion":51,"start":106,"enrollment":107,"conditions":108,"interventions":109},[58],"2021-09-10",60,[30],[42],{"intervention":37,"totalTrials":90,"cells":111},{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":120,"NA":122},{"trials":113,"activeCount":64},[],{"trials":115,"activeCount":64},[],{"trials":117,"activeCount":64},[],{"trials":119,"activeCount":64},[],{"trials":121,"activeCount":64},[],{"trials":123,"activeCount":90,"soonestReadout":36},[124],{"nctId":34,"briefTitle":35,"status":76,"phases":125,"primaryCompletion":36,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":133},[],"2029-12-31","2023-09-10",200,[130,131,132],"Gastric Cancer","Image","Pathology",[37],{"intervention":135,"totalTrials":90,"cells":136},"flax lignans",{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":157,"NA":159},{"trials":138,"activeCount":64},[],{"trials":140,"activeCount":64},[],{"trials":142,"activeCount":64},[],{"trials":144,"activeCount":64},[145],{"nctId":146,"briefTitle":147,"status":148,"phases":149,"completion":150,"start":151,"enrollment":152,"conditions":153,"interventions":156},"NCT00363233","The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus","COMPLETED",[55,56],"2006-12","2006-03",80,[154,155],"Type 2 Diabetes","Hypercholesterolemia",[135],{"trials":158,"activeCount":64},[],{"trials":160,"activeCount":64},[],{"intervention":162,"totalTrials":90,"cells":163},"recombinant human endostatin",{"EARLY_PHASE1":164,"PHASE1":166,"PHASE2":168,"PHASE3":170,"PHASE4":183,"NA":185},{"trials":165,"activeCount":64},[],{"trials":167,"activeCount":64},[],{"trials":169,"activeCount":64},[],{"trials":171,"activeCount":64},[172],{"nctId":173,"briefTitle":174,"status":175,"phases":176,"primaryCompletion":177,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":182},"NCT00576914","Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer","UNKNOWN",[56],"2012-06","2007-06",1108,[181],"Non-small Cell Lung Cancer",[162],{"trials":184,"activeCount":64},[],{"trials":186,"activeCount":64},[],{"intervention":188,"totalTrials":31,"cells":189},"Functional collagen scaffold transplantation",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":205,"PHASE3":217,"PHASE4":219,"NA":221},{"trials":191,"activeCount":64},[],{"trials":193,"activeCount":64},[194],{"nctId":195,"briefTitle":196,"status":148,"phases":197,"primaryCompletion":198,"completion":198,"start":199,"enrollment":200,"conditions":201,"interventions":203},"NCT02754284","Clinical Study of Regeneration on Larynx Soft Tissue Guided by Functional Collagen Scaffold",[54],"2020-06","2015-12",20,[202],"Vocal Cord Dysfunction",[204,188],"Autologous fat transplantation",{"trials":206,"activeCount":64},[207],{"nctId":208,"briefTitle":209,"status":175,"phases":210,"primaryCompletion":211,"completion":211,"start":212,"enrollment":107,"conditions":213,"interventions":215},"NCT04164485","Functional Collagen Scaffold for Laryngeal Soft Tissue Regeneration",[54,55],"2022-12","2019-07-01",[214],"Glottic Insufficiency",[188,216],"Autologous adipose cell transplantation",{"trials":218,"activeCount":64},[],{"trials":220,"activeCount":64},[],{"trials":222,"activeCount":64},[],{"intervention":224,"totalTrials":31,"cells":225},"HUC-MSCs transplantation",{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":255,"PHASE4":257,"NA":259},{"trials":227,"activeCount":64},[],{"trials":229,"activeCount":64},[],{"trials":231,"activeCount":64},[232,243],{"nctId":233,"briefTitle":234,"status":175,"phases":235,"primaryCompletion":236,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT03033277","Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)",[54,55],"2017-04","2018-07","2016-02",320,[241],"Primary Ovarian Insufficiency",[224],{"nctId":244,"briefTitle":245,"status":148,"phases":246,"primaryCompletion":247,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":252},"NCT02644447","Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF",[54,55],"2018-10","2015-10",23,[251],"Premature Ovarian Failure",[253,254],"HUC-MSCs Transplantation","HUC-MSCs with Injectable Collagen Scaffold Transplantation",{"trials":256,"activeCount":64},[],{"trials":258,"activeCount":64},[],{"trials":260,"activeCount":64},[],{"intervention":262,"totalTrials":31,"cells":263},"retinal pigment epithelium transplantation",{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":288,"PHASE4":290,"NA":292},{"trials":265,"activeCount":64},[],{"trials":267,"activeCount":64},[],{"trials":269,"activeCount":64},[270,281],{"nctId":271,"briefTitle":272,"status":175,"phases":273,"primaryCompletion":274,"completion":275,"start":276,"enrollment":277,"conditions":278,"interventions":280},"NCT02755428","Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases",[54,55],"2019-01","2020-12","2018-01",10,[279],"Dry Age-related Macular Degeneration",[262],{"nctId":282,"briefTitle":283,"status":175,"phases":284,"primaryCompletion":274,"completion":275,"start":285,"enrollment":277,"conditions":286,"interventions":287},"NCT03046407","Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells",[54,55],"2017-09-06",[279],[262],{"trials":289,"activeCount":64},[],{"trials":291,"activeCount":64},[],{"trials":293,"activeCount":64},[],{"intervention":295,"totalTrials":31,"cells":296},"Injectable Collagen Scaffold + HUC-MSCs",{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":313,"PHASE3":325,"PHASE4":327,"NA":329},{"trials":298,"activeCount":64},[],{"trials":300,"activeCount":64},[301],{"nctId":302,"briefTitle":303,"status":175,"phases":304,"primaryCompletion":275,"completion":275,"start":305,"enrollment":306,"conditions":307,"interventions":311},"NCT02745808","Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes",[54],"2015-09",30,[308,309,310],"Erectile Dysfunction","Type 1 Diabetes Mellitus","Type 2 Diabetes Mellitus",[312,295],"HUC-MSCs",{"trials":314,"activeCount":64},[315],{"nctId":316,"briefTitle":317,"status":175,"phases":318,"primaryCompletion":275,"completion":275,"start":319,"enrollment":320,"conditions":321,"interventions":323},"NCT02786017","Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis",[54,55],"2016-05",40,[322],"Decompensated Cirrhosis",[324,295],"Conventional therapy",{"trials":326,"activeCount":64},[],{"trials":328,"activeCount":64},[],{"trials":330,"activeCount":64},[],{"intervention":332,"totalTrials":90,"cells":333},"NeuroRegen Scaffold with BMMCs transplantation",{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":349,"PHASE4":351,"NA":353},{"trials":335,"activeCount":64},[],{"trials":337,"activeCount":64},[],{"trials":339,"activeCount":64},[340],{"nctId":341,"briefTitle":342,"status":175,"phases":343,"primaryCompletion":344,"completion":344,"start":345,"enrollment":346,"conditions":347,"interventions":348},"NCT02688062","NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI",[54,55],"2021-12","2016-01",22,[17],[332],{"trials":350,"activeCount":64},[],{"trials":352,"activeCount":64},[],{"trials":354,"activeCount":64},[],{"intervention":356,"totalTrials":90,"cells":357},"NeuroRegen scaffold\u002Fmesenchymal stem cells transplantation",{"EARLY_PHASE1":358,"PHASE1":360,"PHASE2":362,"PHASE3":371,"PHASE4":373,"NA":375},{"trials":359,"activeCount":64},[],{"trials":361,"activeCount":64},[],{"trials":363,"activeCount":64},[364],{"nctId":365,"briefTitle":366,"status":175,"phases":367,"primaryCompletion":344,"completion":344,"start":345,"enrollment":306,"conditions":368,"interventions":369},"NCT02688049","NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair",[54,55],[17],[356,370],"NeuroRegen scaffold\u002Fneural stem cells transplantation",{"trials":372,"activeCount":64},[],{"trials":374,"activeCount":64},[],{"trials":376,"activeCount":64},[],{"intervention":370,"totalTrials":90,"cells":378},{"EARLY_PHASE1":379,"PHASE1":381,"PHASE2":383,"PHASE3":389,"PHASE4":391,"NA":393},{"trials":380,"activeCount":64},[],{"trials":382,"activeCount":64},[],{"trials":384,"activeCount":64},[385],{"nctId":365,"briefTitle":366,"status":175,"phases":386,"primaryCompletion":344,"completion":344,"start":345,"enrollment":306,"conditions":387,"interventions":388},[54,55],[17],[356,370],{"trials":390,"activeCount":64},[],{"trials":392,"activeCount":64},[],{"trials":394,"activeCount":64},[],{"intervention":396,"totalTrials":90,"cells":397},"NeuroRegen scaffold\u002FBMMCs transplantation",{"EARLY_PHASE1":398,"PHASE1":400,"PHASE2":402,"PHASE3":413,"PHASE4":415,"NA":417},{"trials":399,"activeCount":64},[],{"trials":401,"activeCount":64},[],{"trials":403,"activeCount":64},[404],{"nctId":405,"briefTitle":406,"status":175,"phases":407,"primaryCompletion":275,"completion":275,"start":345,"enrollment":408,"conditions":409,"interventions":411},"NCT02648386","Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery",[54,55],34,[410,308],"Rectal Cancer",[396,412],"NeuroRegen scaffold\u002FHUC-MSCs transplantation",{"trials":414,"activeCount":64},[],{"trials":416,"activeCount":64},[],{"trials":418,"activeCount":64},[],{"intervention":412,"totalTrials":90,"cells":420},{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":425,"PHASE3":431,"PHASE4":433,"NA":435},{"trials":422,"activeCount":64},[],{"trials":424,"activeCount":64},[],{"trials":426,"activeCount":64},[427],{"nctId":405,"briefTitle":406,"status":175,"phases":428,"primaryCompletion":275,"completion":275,"start":345,"enrollment":408,"conditions":429,"interventions":430},[54,55],[410,308],[396,412],{"trials":432,"activeCount":64},[],{"trials":434,"activeCount":64},[],{"trials":436,"activeCount":64},[],{"intervention":254,"totalTrials":90,"cells":438},{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":449,"PHASE4":451,"NA":453},{"trials":440,"activeCount":64},[],{"trials":442,"activeCount":64},[],{"trials":444,"activeCount":64},[445],{"nctId":244,"briefTitle":245,"status":148,"phases":446,"primaryCompletion":247,"completion":247,"start":248,"enrollment":249,"conditions":447,"interventions":448},[54,55],[251],[253,254],{"trials":450,"activeCount":64},[],{"trials":452,"activeCount":64},[],{"trials":454,"activeCount":64},[],{"intervention":456,"totalTrials":90,"cells":457},"Collagen membrane + HUC-MSCs",{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":473,"PHASE4":475,"NA":477},{"trials":459,"activeCount":64},[],{"trials":461,"activeCount":64},[],{"trials":463,"activeCount":64},[464],{"nctId":465,"briefTitle":466,"status":175,"phases":467,"primaryCompletion":344,"completion":344,"start":468,"enrollment":469,"conditions":470,"interventions":472},"NCT02947191","Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation",[54,55],"2016-11",12,[471],"Chronic Nasal Septum Perforation",[456],{"trials":474,"activeCount":64},[],{"trials":476,"activeCount":64},[],{"trials":478,"activeCount":64},[],{"intervention":480,"totalTrials":90,"cells":481},"hUC-MSCs+Injectable collagen scaffold+CABG",{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":486,"PHASE3":498,"PHASE4":500,"NA":502},{"trials":483,"activeCount":64},[],{"trials":485,"activeCount":64},[],{"trials":487,"activeCount":64},[488],{"nctId":489,"briefTitle":490,"status":148,"phases":491,"primaryCompletion":492,"completion":492,"start":248,"enrollment":493,"conditions":494,"interventions":496},"NCT02635464","Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy",[54,55],"2019-08",50,[495],"Chronic Ischemic Cardiomyopathy",[480,497],"hUC-MSCs+CABG",{"trials":499,"activeCount":64},[],{"trials":501,"activeCount":64},[],{"trials":503,"activeCount":64},[],{"intervention":497,"totalTrials":90,"cells":505},{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":516,"PHASE4":518,"NA":520},{"trials":507,"activeCount":64},[],{"trials":509,"activeCount":64},[],{"trials":511,"activeCount":64},[512],{"nctId":489,"briefTitle":490,"status":148,"phases":513,"primaryCompletion":492,"completion":492,"start":248,"enrollment":493,"conditions":514,"interventions":515},[54,55],[495],[480,497],{"trials":517,"activeCount":64},[],{"trials":519,"activeCount":64},[],{"trials":521,"activeCount":64},[],{"intervention":216,"totalTrials":90,"cells":523},{"EARLY_PHASE1":524,"PHASE1":526,"PHASE2":528,"PHASE3":534,"PHASE4":536,"NA":538},{"trials":525,"activeCount":64},[],{"trials":527,"activeCount":64},[],{"trials":529,"activeCount":64},[530],{"nctId":208,"briefTitle":209,"status":175,"phases":531,"primaryCompletion":211,"completion":211,"start":212,"enrollment":107,"conditions":532,"interventions":533},[54,55],[214],[188,216],{"trials":535,"activeCount":64},[],{"trials":537,"activeCount":64},[],{"trials":539,"activeCount":64},[],{"intervention":324,"totalTrials":90,"cells":541},{"EARLY_PHASE1":542,"PHASE1":544,"PHASE2":546,"PHASE3":552,"PHASE4":554,"NA":556},{"trials":543,"activeCount":64},[],{"trials":545,"activeCount":64},[],{"trials":547,"activeCount":64},[548],{"nctId":316,"briefTitle":317,"status":175,"phases":549,"primaryCompletion":275,"completion":275,"start":319,"enrollment":320,"conditions":550,"interventions":551},[54,55],[322],[324,295],{"trials":553,"activeCount":64},[],{"trials":555,"activeCount":64},[],{"trials":557,"activeCount":64},[],{"intervention":559,"totalTrials":90,"cells":560},"CAStem",{"EARLY_PHASE1":561,"PHASE1":563,"PHASE2":565,"PHASE3":579,"PHASE4":581,"NA":583},{"trials":562,"activeCount":64},[],{"trials":564,"activeCount":64},[],{"trials":566,"activeCount":64},[567],{"nctId":568,"briefTitle":569,"status":175,"phases":570,"primaryCompletion":275,"completion":275,"start":571,"enrollment":572,"conditions":573,"interventions":578},"NCT04331613","Safety and Efficacy of CAStem for Severe COVID-19 Associated With\u002FWithout ARDS",[54,55],"2020-01-27",9,[574,575,576,577],"COVID-19","Acute Respiratory Distress Syndrome","Virus; Pneumonia","Acute Lung Injury",[559],{"trials":580,"activeCount":64},[],{"trials":582,"activeCount":64},[],{"trials":584,"activeCount":64},[],{"intervention":586,"totalTrials":90,"cells":587},"NPC transplantation",{"EARLY_PHASE1":588,"PHASE1":590,"PHASE2":592,"PHASE3":604,"PHASE4":606,"NA":608},{"trials":589,"activeCount":64},[],{"trials":591,"activeCount":64},[],{"trials":593,"activeCount":64},[594],{"nctId":595,"briefTitle":596,"status":175,"phases":597,"primaryCompletion":598,"completion":275,"start":599,"enrollment":493,"conditions":600,"interventions":602},"NCT03119636","Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease",[54,55],"2018-11","2017-05",[601],"Parkinson's Disease",[586,603],"Levodopa",{"trials":605,"activeCount":64},[],{"trials":607,"activeCount":64},[],{"trials":609,"activeCount":64},[],{"intervention":603,"totalTrials":90,"cells":611},{"EARLY_PHASE1":612,"PHASE1":614,"PHASE2":616,"PHASE3":622,"PHASE4":624,"NA":626},{"trials":613,"activeCount":64},[],{"trials":615,"activeCount":64},[],{"trials":617,"activeCount":64},[618],{"nctId":595,"briefTitle":596,"status":175,"phases":619,"primaryCompletion":598,"completion":275,"start":599,"enrollment":493,"conditions":620,"interventions":621},[54,55],[601],[586,603],{"trials":623,"activeCount":64},[],{"trials":625,"activeCount":64},[],{"trials":627,"activeCount":64},[],{"intervention":629,"totalTrials":90,"cells":630},"Functional scaffold & Epidural Electrical Stimulation",{"EARLY_PHASE1":631,"PHASE1":633,"PHASE2":635,"PHASE3":644,"PHASE4":646,"NA":648},{"trials":632,"activeCount":64},[],{"trials":634,"activeCount":64},[],{"trials":636,"activeCount":64},[637],{"nctId":638,"briefTitle":639,"status":175,"phases":640,"primaryCompletion":344,"completion":344,"start":641,"enrollment":572,"conditions":642,"interventions":643},"NCT03966794","Functional Scaffold Transplantation Combined With Epidural Electrical Stimulation for Spinal Cord Injury Repair",[54,55],"2019-08-01",[17],[629],{"trials":645,"activeCount":64},[],{"trials":647,"activeCount":64},[],{"trials":649,"activeCount":64},[],{"intervention":651,"totalTrials":90,"cells":652},"Functional collagen scaffold",{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":665,"PHASE3":667,"PHASE4":669,"NA":671},{"trials":654,"activeCount":64},[],{"trials":656,"activeCount":64},[657],{"nctId":658,"briefTitle":659,"status":175,"phases":660,"primaryCompletion":344,"completion":344,"start":661,"enrollment":200,"conditions":662,"interventions":664},"NCT02510365","Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients",[54],"2015-04",[663],"Acute Spinal Cord Injury",[651],{"trials":666,"activeCount":64},[],{"trials":668,"activeCount":64},[],{"trials":670,"activeCount":64},[],{"trials":672,"activeCount":64},[],{"intervention":204,"totalTrials":90,"cells":674},{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":683,"PHASE3":685,"PHASE4":687,"NA":689},{"trials":676,"activeCount":64},[],{"trials":678,"activeCount":64},[679],{"nctId":195,"briefTitle":196,"status":148,"phases":680,"primaryCompletion":198,"completion":198,"start":199,"enrollment":200,"conditions":681,"interventions":682},[54],[202],[204,188],{"trials":684,"activeCount":64},[],{"trials":686,"activeCount":64},[],{"trials":688,"activeCount":64},[],{"trials":690,"activeCount":64},[],{"intervention":692,"totalTrials":90,"cells":693},"NeuroRegen scaffold with BMMCs or MSCs transplantation",{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":705,"PHASE3":707,"PHASE4":709,"NA":711},{"trials":695,"activeCount":64},[],{"trials":697,"activeCount":64},[698],{"nctId":699,"briefTitle":700,"status":175,"phases":701,"primaryCompletion":344,"completion":344,"start":702,"enrollment":306,"conditions":703,"interventions":704},"NCT02352077","NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair",[54],"2015-01",[17],[692],{"trials":706,"activeCount":64},[],{"trials":708,"activeCount":64},[],{"trials":710,"activeCount":64},[],{"trials":712,"activeCount":64},[],{"intervention":714,"totalTrials":90,"cells":715},"Cell therapy",{"EARLY_PHASE1":716,"PHASE1":718,"PHASE2":730,"PHASE3":732,"PHASE4":734,"NA":736},{"trials":717,"activeCount":64},[],{"trials":719,"activeCount":64},[720],{"nctId":721,"briefTitle":722,"status":175,"phases":723,"primaryCompletion":724,"completion":725,"start":726,"enrollment":727,"conditions":728,"interventions":729},"NCT03877471","Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency",[54],"2020-07-01","2021-12-31","2019-04-03",28,[241],[714],{"trials":731,"activeCount":64},[],{"trials":733,"activeCount":64},[],{"trials":735,"activeCount":64},[],{"trials":737,"activeCount":64},[],{"intervention":312,"totalTrials":90,"cells":739},{"EARLY_PHASE1":740,"PHASE1":742,"PHASE2":748,"PHASE3":750,"PHASE4":752,"NA":754},{"trials":741,"activeCount":64},[],{"trials":743,"activeCount":64},[744],{"nctId":302,"briefTitle":303,"status":175,"phases":745,"primaryCompletion":275,"completion":275,"start":305,"enrollment":306,"conditions":746,"interventions":747},[54],[308,309,310],[312,295],{"trials":749,"activeCount":64},[],{"trials":751,"activeCount":64},[],{"trials":753,"activeCount":64},[],{"trials":755,"activeCount":64},[],{"intervention":757,"totalTrials":90,"cells":758},"MSCs Transplantation",{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":772,"PHASE3":774,"PHASE4":776,"NA":778},{"trials":760,"activeCount":64},[],{"trials":762,"activeCount":64},[763],{"nctId":764,"briefTitle":765,"status":175,"phases":766,"primaryCompletion":344,"completion":344,"start":767,"enrollment":306,"conditions":768,"interventions":770},"NCT02767817","Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury",[54],"2016-03",[769],"Brain Injury",[757,771],"Injectable Collagen Scaffold with MSCs Transplantation",{"trials":773,"activeCount":64},[],{"trials":775,"activeCount":64},[],{"trials":777,"activeCount":64},[],{"trials":779,"activeCount":64},[],{"intervention":771,"totalTrials":90,"cells":781},{"EARLY_PHASE1":782,"PHASE1":784,"PHASE2":790,"PHASE3":792,"PHASE4":794,"NA":796},{"trials":783,"activeCount":64},[],{"trials":785,"activeCount":64},[786],{"nctId":764,"briefTitle":765,"status":175,"phases":787,"primaryCompletion":344,"completion":344,"start":767,"enrollment":306,"conditions":788,"interventions":789},[54],[769],[757,771],{"trials":791,"activeCount":64},[],{"trials":793,"activeCount":64},[],{"trials":795,"activeCount":64},[],{"trials":797,"activeCount":64},[],{"intervention":799,"totalTrials":11,"cells":800},"Indocyanine green",{"EARLY_PHASE1":801,"PHASE1":803,"PHASE2":816,"PHASE3":818,"PHASE4":820,"NA":822},{"trials":802,"activeCount":64},[],{"trials":804,"activeCount":64},[805],{"nctId":806,"briefTitle":807,"status":148,"phases":808,"primaryCompletion":809,"completion":809,"start":810,"enrollment":811,"conditions":812,"interventions":815},"NCT02611245","NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG",[54],"2016-10","2015-08",36,[813,814],"Lung Cancer","Esophageal Cancer",[799],{"trials":817,"activeCount":64},[],{"trials":819,"activeCount":64},[],{"trials":821,"activeCount":64},[],{"trials":823,"activeCount":64},[824,834],{"nctId":825,"briefTitle":826,"status":148,"phases":827,"primaryCompletion":305,"completion":305,"start":828,"enrollment":829,"conditions":830,"interventions":832},"NCT02084784","Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research",[58],"2014-01",98,[831,26],"Sentinel Lymph Node",[799,833],"methylene blue",{"nctId":835,"briefTitle":836,"status":148,"phases":837,"primaryCompletion":838,"completion":839,"start":840,"enrollment":841,"conditions":842,"interventions":843},"NCT03579979","Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG",[58],"2019-08-30","2020-08-19","2017-08-24",130,[831,26],[844,845],"Methylene Blue","Indocyanine Green",{"intervention":833,"totalTrials":31,"cells":847},{"EARLY_PHASE1":848,"PHASE1":850,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":858},{"trials":849,"activeCount":64},[],{"trials":851,"activeCount":64},[],{"trials":853,"activeCount":64},[],{"trials":855,"activeCount":64},[],{"trials":857,"activeCount":64},[],{"trials":859,"activeCount":64},[860,864],{"nctId":825,"briefTitle":826,"status":148,"phases":861,"primaryCompletion":305,"completion":305,"start":828,"enrollment":829,"conditions":862,"interventions":863},[58],[831,26],[799,833],{"nctId":835,"briefTitle":836,"status":148,"phases":865,"primaryCompletion":838,"completion":839,"start":840,"enrollment":841,"conditions":866,"interventions":867},[58],[831,26],[844,845],{"intervention":869,"totalTrials":90,"cells":870},"FluoAB",{"EARLY_PHASE1":871,"PHASE1":873,"PHASE2":875,"PHASE3":877,"PHASE4":879,"NA":881},{"trials":872,"activeCount":64},[],{"trials":874,"activeCount":64},[],{"trials":876,"activeCount":64},[],{"trials":878,"activeCount":64},[],{"trials":880,"activeCount":64},[],{"trials":882,"activeCount":64},[883],{"nctId":884,"briefTitle":885,"status":175,"phases":886,"primaryCompletion":887,"completion":888,"start":889,"enrollment":107,"conditions":890,"interventions":892},"NCT05394246","Fluorescent-labeled IgG for Liver Tumor Detection",[58],"2024-12-31","2025-06-30","2022-05-20",[891],"Liver Cancer",[869],{"intervention":894,"totalTrials":90,"cells":895},"Glipizide",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":906},{"trials":897,"activeCount":64},[],{"trials":899,"activeCount":64},[],{"trials":901,"activeCount":64},[],{"trials":903,"activeCount":64},[],{"trials":905,"activeCount":64},[],{"trials":907,"activeCount":64},[908],{"nctId":909,"briefTitle":910,"status":148,"phases":911,"completion":912,"start":913,"enrollment":914,"conditions":915,"interventions":918},"NCT01082796","Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects",[58],"2010-01","2009-11",14,[916,917],"Genotype","Pharmacokinetic",[894],{"intervention":920,"totalTrials":90,"cells":921},"methotrexate",{"EARLY_PHASE1":922,"PHASE1":924,"PHASE2":926,"PHASE3":928,"PHASE4":930,"NA":932},{"trials":923,"activeCount":64},[],{"trials":925,"activeCount":64},[],{"trials":927,"activeCount":64},[],{"trials":929,"activeCount":64},[],{"trials":931,"activeCount":64},[],{"trials":933,"activeCount":64},[934],{"nctId":935,"briefTitle":936,"status":148,"phases":937,"primaryCompletion":938,"completion":938,"start":939,"enrollment":277,"conditions":940,"interventions":942},"NCT01619176","Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood",[58],"2014-12","2012-10",[941],"Rheumatoid Arthritis",[920,943,944,920,943,944],"non-steroidal anti-inflammatory drug","leflunomide",{"intervention":943,"totalTrials":90,"cells":946},{"EARLY_PHASE1":947,"PHASE1":949,"PHASE2":951,"PHASE3":953,"PHASE4":955,"NA":957},{"trials":948,"activeCount":64},[],{"trials":950,"activeCount":64},[],{"trials":952,"activeCount":64},[],{"trials":954,"activeCount":64},[],{"trials":956,"activeCount":64},[],{"trials":958,"activeCount":64},[959],{"nctId":935,"briefTitle":936,"status":148,"phases":960,"primaryCompletion":938,"completion":938,"start":939,"enrollment":277,"conditions":961,"interventions":962},[58],[941],[920,943,944,920,943,944],{"intervention":944,"totalTrials":90,"cells":964},{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":969,"PHASE3":971,"PHASE4":973,"NA":975},{"trials":966,"activeCount":64},[],{"trials":968,"activeCount":64},[],{"trials":970,"activeCount":64},[],{"trials":972,"activeCount":64},[],{"trials":974,"activeCount":64},[],{"trials":976,"activeCount":64},[977],{"nctId":935,"briefTitle":936,"status":148,"phases":978,"primaryCompletion":938,"completion":938,"start":939,"enrollment":277,"conditions":979,"interventions":980},[58],[941],[920,943,944,920,943,944],{"intervention":982,"totalTrials":90,"cells":983},"split-virion, H1N1 vaccine of 15 μg",{"EARLY_PHASE1":984,"PHASE1":986,"PHASE2":988,"PHASE3":990,"PHASE4":992,"NA":994},{"trials":985,"activeCount":64},[],{"trials":987,"activeCount":64},[],{"trials":989,"activeCount":64},[],{"trials":991,"activeCount":64},[],{"trials":993,"activeCount":64},[],{"trials":995,"activeCount":64},[996],{"nctId":997,"briefTitle":998,"status":175,"phases":999,"primaryCompletion":1000,"completion":1001,"start":1002,"enrollment":200,"conditions":1003,"interventions":1005},"NCT01096225","Immunogenicity Study of S-OIV H1N1 Influenza Vaccine",[],"2010-04","2010-08","2010-03",[1004],"Human Influenza",[982]]